# CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair

Study · id `cardio:ct-nct06814210` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06814210](<https://clinicaltrials.gov/study/NCT06814210>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06814210

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06814210. Randomized; single masking; primary purpose prevention. Start 2025-03-01 (anticipated); primary completion 2025-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06814210, source copy `cardio:ctgov-nct06814210-2025-02-07`, retrieved 2026-10-26)
- Planned start: 2025-03-01 (anticipated) (ClinicalTrials.gov record NCT06814210, source copy `cardio:ctgov-nct06814210-2025-02-07`, retrieved 2026-10-26)
- Primary completion: 2025-09-30 (anticipated) (ClinicalTrials.gov record NCT06814210, source copy `cardio:ctgov-nct06814210-2025-02-07`, retrieved 2026-10-26)
- Completion: 2025-10-31 (anticipated) (ClinicalTrials.gov record NCT06814210, source copy `cardio:ctgov-nct06814210-2025-02-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06814210, source copy `cardio:ctgov-nct06814210-2025-02-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06814210-2025-02-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair
- Condition: Mitral Regurgitation
- Condition: Functional Mitral Regurgitation
- Condition: Degenerative Mitral Valve Regurgitation
- Intervention (Device): Cerebral Embolic Protection
- Lead sponsor: Xiao-dong Zhuang
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Xiao-dong Zhuang (`cardio:org-xiao-dong-zhuang`)

## Provenance

Content hash: 7a00b6da87da979efa50a552b6938b934d28068a0f10d90e6e3d44100b219172
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
